Sandra Adamson Fryhofer, MD, MACP, FRCP DISCLOSURES February 12, 2020 This transcript has been edited for clarity. Hello. I’m Dr Sandra Fryhofer. Welcome to Medicine Matters. The topic? HPV vaccine for mid-life adults. Who needs it? Who doesn’t? A new study was published in JAMA Network. HPV, the human papilloma virus, causes cancer—as many as...
Tag: <span>prophylactic</span>
Post
Charcoal-based drug delivery system improves efficacy of common herpes drug
by Sharon Parmet, University of Illinois at Chicago A study led by researchers from the University of Illinois at Chicago has found that combining acyclovir—a commonly prescribed topical herpes medication—with particles of activated carbon improves efficacy of the drug. This new approach allows for less frequent dosing and overall course of treatment while providing some...